ORIGINAL RESEARCH
Accepted on 12 Aug 2025
Reduced-Dose Obinutuzumab Induces Remission in Refractory ANCA-Associated Vasculitis: A Report of 16 Cases
doi 10.3389/fimmu.2025.1624234
- 120 views
871
Total downloads
5,419
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
ORIGINAL RESEARCH
Accepted on 12 Aug 2025
CASE REPORT
Published on 09 May 2025
REVIEW
Published on 30 Apr 2025
BRIEF RESEARCH REPORT
Published on 04 Apr 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: